May 2 |
The top pharmaceutical companies by R&D expenditure
|
May 2 |
Decoding Johnson & Johnson (JNJ): A Strategic SWOT Insight
|
May 1 |
US STOCKS-S&P 500, Nasdaq end lower after Fed rate decision, Powell press conference
|
May 1 |
Sector Update: Health Care Stocks Rise Late Afternoon
|
May 1 |
US not suffering from ‘stagflation’, says Fed chairman Jerome Powell
|
May 1 |
US STOCKS-S&P 500 ends lower after Fed rate decision, Powell press conference
|
May 1 |
Johnson & Johnson’s latest gambit to solve its massive talcum powder asbestos issue: A $6.5 billion settlement, paid out over 25 years
|
May 1 |
J&J Offers $6.5 Billion for Talc Lawsuits Ahead of Third Bankruptcy Filing
|
May 1 |
Janssen adopts J&J name as part of global rebranding effort
|
May 1 |
J&J Seeks Backing for $11 Billion Baby Powder Cancer Deal
|